Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung; Disease, Interstitial, With Fibrosis”

452 trials

Showing 20 of 452 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Testing effectiveness (Phase 2)Study completedNCT04461587
What this trial is testing

Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis

Who this might be right for
Coal Workers' Pneumoconiosis (Complicated)
Pulmonary Research of Abingdon, LLC 50
Early research (Phase 1)Study completedNCT02648048
What this trial is testing

Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 21
Not applicableUnknownNCT03215147
What this trial is testing

Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisAirway Disease
Seoul National University Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT01135199
What this trial is testing

Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Stanford University
Not applicableStudy completedNCT03981406
What this trial is testing

Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisDepressionAnxiety+3 more
University of Minnesota 22
Not applicableStudy completedNCT06650774
What this trial is testing

Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Karadeniz Technical University 152
Testing effectiveness (Phase 2)Ended earlyNCT06317285
What this trial is testing

Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 158
Not applicableUnknownNCT04179058
What this trial is testing

Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up

Who this might be right for
Idiopathic Interstitial Pneumonia
Central Hospital, Nancy, France 300
Early research (Phase 1)UnknownNCT05387785
What this trial is testing

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Angion Biomedica Corp 20
Not applicableStudy completedNCT05711290
What this trial is testing

Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of Oxford 28
Testing effectiveness (Phase 2)Study completedNCT05938920
What this trial is testing

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
InSilico Medicine Hong Kong Limited 71
Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)Study completedNCT00352482
What this trial is testing

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
National Heart, Lung, and Blood Institute (NHLBI) 20
Testing effectiveness (Phase 2)Study completedNCT02707640
What this trial is testing

Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 123
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Testing effectiveness (Phase 2)Study completedNCT05722964
What this trial is testing

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Large-scale testing (Phase 3)Study completedNCT01979952
What this trial is testing

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 113
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Not applicableStudy completedNCT03281200
What this trial is testing

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 172
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation